restiffic® restless leg foot wrap stars on Lifetime Television®

Jun 2, 2017 - (Newswire)

- The restiffic compressive foot wrap for Restless Leg Syndrome (RLS) will be featured on The Balancing Act® morning show airing on Lifetime Television. The Balancing Act's segment on RLS and this revolutionary new drug-free therapy will air at 7:30 a.m. ET/PT on June 5 and June 12, 2017.

The Balancing Act's segment on treating RLS with restiffic features Sandie & Paul Yeaman, a couple from Omaha, NE whose lives were consumed by Sandie's severe RLS before they discovered restiffic, and Daniel Olson, a doctor of podiatric medicine from Erie, PA who was the lead investigator in restiffic's successful clinical trial.

Paul reminisced that his wife, Sandie, "was the biggest skeptic in the world, but I was willing to try anything that might help her." His persistence paid off, and Sandie gushes that "The first time I tried restiffic…instantly, my legs calmed down. It was like I almost forgot that I had restless legs for the first time ever."

"RLS is traditionally treated with opioids and powerful narcotics which may help patients' symptoms partially, but the side effects that many patients experience far outweigh the benefits," says Dr. Olson. "With restiffic, we've found a safe and effective alternative to traditional medication."

restiffic offers affordable drug-free therapy for patients suffering from RLS and can be purchased online with a prescription at www.restiffic.com.

About medi USA

medi has over 65 years of experience in manufacturing medical devices and is a global leader in the medical compression, orthopedic, foot orthotic, and sports medicine markets. Proudly manufactured in the USA, restiffic is a new addition to the medi USA portfolio. View the entire medi catalog at www.mediusa.com.

Media Contact
Maggie Moriarty
800-633-6334 x172


Related Links


Original Source: https://www.newswire.com/news/restiffic-restless-leg-foot-wrap-stars-on-lifetime-television

What Next?

Related Articles

Leave a Reply

Submit Comment